Atlas Trials

Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency

Clinical trial NCT03874013 · COMPLETED

Trial details

NCT number
NCT03874013
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Growth Hormone Deficiency
Start date
2017-12-07
Primary completion
2020-03-06
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.